Rhode Island S2863 requires the state and private insurers to dispense up to a year's supply of prescription hormone therapy as a single prescription.
Rhode Island S2863 mandates that the state and private insurers providing prescription hormone therapy coverage must dispense up to a year's supply as a single prescription, starting January 1, 2027. This applies unless the enrollee requests a smaller supply, the prescribing provider instructs otherwise, or the therapy is a controlled substance. The bill also allows health plans to apply drug utilization management strategies to covered drugs. It does not apply to certain limited-benefit insurance policies.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.